[Effect of joint administration of antagonists of serotonin, histamine and acetylcholine on ventilatory disorders in asthma].
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000328:Adult; D000368:Aged; D000420:Albuterol / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D008168:Lung / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010918:Pizotyline / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use*
D006633:Histamine Antagonists; D012702:Serotonin Antagonists; D013876:Thiophenes; D010918:Pizotyline; D000109:Acetylcholine; D000420:Albuterol
Wpływ łacznego stosowania antagonistów serotoniny, histaminy i acetylocholiny na zaburzenia wentylacyjne w dychawicy oskrzelowej.